c-Src Is Required for Oxidative Stress-mediated Activation of Big Mitogen-activated Protein Kinase 1 (BMK1)*

(Received for publication, May 29, 1997)

Jun-ichi Abe , Masafumi Takahashi , Mari Ishida , Jiing-Dwan Lee Dagger and Bradford C. Berk §

From the Department of Medicine, Cardiology Division, University of Washington, Seattle, Washington 98195 and the Dagger  Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES


ABSTRACT

Big mitogen-activated kinase 1 (BMK1) or extracellular signal-regulated kinase-5 (ERK5) has recently been identified as a new member of the mitogen-activated protein kinase family. We have shown that BMK1 is activated to a greater extent by H2O2 than growth factors, suggesting that in comparison with other mitogen-activated protein kinase family members, BMK1 is a redox-sensitive kinase. Previous investigations indicate that the tyrosine kinase c-Src mediates signal transduction by reactive oxygen species, including H2O2. Therefore, the role of Src kinase family members (c-Src and Fyn) in activation of the BMK1 by H2O2 in mouse fibroblasts was studied. An essential role for c-Src was suggested by four experiments. First, H2O2 stimulated c-Src activity rapidly in fibroblasts (peak at 5 min), which preceded peak activity of BMK1 (20 min). Second, specific Src family tyrosine kinase inhibitors (herbimycin A and CP-118,556) blocked BMK1 activation by H2O2 in a concentration-dependent manner. Third, BMK1 activation in the response to H2O2 was completely inhibited in cells derived from mice deficient in c-Src, but not Fyn. Finally, BMK1 activity was much greater in v-Src-transformed NIH-3T3 cells than wild type cells. These results demonstrate an essential role for c-Src in H2O2-mediated activation of BMK1 and suggest that redox-sensitive regulation of BMK1 is a new function for c-Src.


INTRODUCTION

The MAP1 kinases are activated by diverse stimuli to transduce signals from the cell membrane to the nucleus (1). Three MAP kinase groups may be defined based on their dual phosphorylation motifs, TEY, TPY, and TGY, which we will term ERK1/2 (2), c-Jun N-terminal kinase (JNK/SAPK) (3, 4), and p38 (5), respectively. Each MAP kinase group has relatively distinct upstream activators and substrate specificities. For example, growth factors and phorbol esters readily activate ERK1/2, but have little effect on JNK/SAPK; while UV irradiation and anisomycin are much better activators of JNK/SAPK than of ERK1/2 or p38. Similarly, ERK1/2 phosphorylates ternary complex factor/Elk-1 (6), while the transcription factor c-Jun is a specific substrate for the JNK/SAPK signaling pathway (3, 4). Common pathways also exist as shown by the fact that both JNK/SAPK and p38 are activated by apoptosis (7), and both kinases phosphorylate and regulate activating transcription factor 2 (8, 9).

A new MAP kinase family member termed BMK1 or ERK5 was cloned recently (10, 11). BMK1 has a TEY sequence in its dual phosphorylation site, like ERK1/2, but it has unique carboxyl-terminal and loop-12 domains compared with ERK1/2. We have shown that activation of BMK1 in rat aortic smooth muscle cells is distinct from activation of ERK1/2. In particular, BMK1 participates in a redox-sensitive pathway activated by H2O2 but not by agonists such as phorbol ester, angiotensin II, platelet-derived growth factor, and tumor necrosis factor-alpha (12). Specific activation of BMK1 by oxidative stress suggests that BMK1 may represent a unique redox-sensitive kinase compared with other MAP kinase family members.

Reactive oxygen species, including H2O2, O2-, and OH-, have been implicated in the pathogenesis of cardiovascular disease, especially atherosclerosis and hypertension (13-15). Recently, it has been shown that these molecules and growth factors stimulate similar intracellular signal events including activating kinases such as c-Src and ERK1/2 (16, 17). We have demonstrated that BMK1, a member of the MAP kinase family, is specifically activated by oxidative and osmotic stress (12). Thus the the upstream signal mechanisms by which H2O2 activates BMK1 should provide valuable insights into pathways of redox-sensitive signal transduction. Previous studies have shown that c-Src is involved in signal events stimulated by reactive oxygen species (16). Several receptors that lack intrinsic tyrosine kinase activity stimulate tyrosine phosphorylation through association with Src family kinases such as Lck, Lyn, and Fyn (18). To determine whether Src family kinases are involved in H2O2-mediated activation of BMK1, we investigated the role of Src kinases in cultured mouse fibroblasts using both specific Src inhibitors and cells derived from animals deficient in c-Src or Fyn. We show here that activation of BMK1 by H2O2 is positively regulated by c-Src, but not Fyn. Thus, the c-Src-BMK1 signaling pathway may represent a new redox-sensitive mechanism in fibroblasts.


EXPERIMENTAL PROCEDURES

Cell Lines and Culture

The Src-/-, and Fyn-/- fibroblasts were isolated from mouse embryos, which were homozygous for disruption in Src or Fyn gene, and were immortalized with large T antigen (19, 20). Cells were kindly provided by Sheila M. Thomas (Fred Hutchinson Cancer Center, Seattle). NIH-3T3 cells and v-src-transformed NIH-3T3 cells were kindly provided by David Shalloway (21). Fibroblasts were maintained in Dulbecco's modified Eagle's medium supplemented with 10% calf serum as described previously (19). Cells at 70-80% confluence in 100-mm dishes were growth arrested by incubation in 0.4% calf serum, Dulbecco's modified Eagle's medium for 48 h prior to use.

Immunoprecipitation and Western Blot Analysis

After treatment, the cells were washed with PBS, harvested in 0.5 ml of lysis buffer (50 mM sodium pyrophosphate, 50 mM NaF, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, 100 µM Na3VO4, 10 mM HEPES, pH 7.4, 0.1% Triton X-100, 500 µM phenylmethanesulfonyl fluoride, and 10 µg/ml leupeptin), and flash-frozen on a dry ice/ethanol bath. After allowing the cells to thaw, cells were scraped off the dish and centrifuged at 14,000 × g (4 °C for 30 min), and protein concentration was determined using the Bradford protein assay (Bio-Rad). For immunoprecipitation, cell lysates were incubated with rabbit anti-BMK1 antibody (3 µl) or preimmune serum for 3 h at 4 °C and then incubated with 20 µl of protein A-Sepharose CL-4B (Pharmacia Biotech Inc.) for 1 h on a roller system at 4 °C. The beads were washed two times with 1 ml of lysis buffer, 2 times with 1 ml of LiCl wash buffer (500 mM LiCl, 100 mM Tris-Cl, pH 7.6, 0.1% Triton X-100, 1 mM DTT), and 2 times in 1 ml of washing buffer (20 mM HEPES, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 1 mM DTT, 0.1% Triton X-100). For Western blot analysis, immunoprecipitates were subjected to SDS-PAGE, and proteins were transferred to nitrocellulose membranes (HybondTM-ECL (enhanced chemiluminescence), Amersham International) as described previously (12). The membrane was blocked for 1 h at room temperature with a commercial blocking buffer from Life Technologies, Inc. The blots were then incubated for 4 h at room temperature with the BMK1 antibody, followed by incubation for 1 h with secondary antibody (horseradish peroxidase-conjugated). Immunoreactive bands were visualized using ECL (Amersham International).

BMK1 and c-Src Kinase Assays

BMK1 kinase activity was measured by autophosphorylation and myelin basic phosphorylation as described previously with slight modification (12). Comparison of BMK1 activity measured by 32P incorporation into soluble myelin basic protein versus autophosphorylation of BMK1 showed a good correlation between the two techniques. Because autophosphorylation of immunoprecipitated BMK1 was more robust than myelin basic protein phosphorylation, we report only results from autophosphorylation assays. Cells were harvested in lysis buffer at 4 °C, then flash-frozen on a dry ice/ethanol bath. After allowing the cells to thaw, cells were scraped off the dish and centrifuged at 14,000 × g (4 °C for 30 min), and protein concentration were determined. BMK1 was immunoprecipitated by incubating 400 µg of protein from each sample with 3 µl of the rabbit polyclonal anti-BMK1 antibody for 3 h and adding 40 µl of a 1:1 slurry of protein A-Sepharose (Pharmacia) beads to the extract/antibody mixture and incubation for 1 h at 4 °C. The beads were washed two times with 1 ml of lysis buffer, 2 times with 1 ml of LiCl wash buffer (500 mM LiCl, 100 mM Tris-Cl, pH 7.6, 0.1% Triton X-100, 1 mM DTT), and two times in 1 ml of modified Buffer A (20 mM HEPES, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 1 mM DTT, 0.1%Triton X-100). BMK1 kinase activity of the immunoprecipitate was measured at 30 °C for 20 min in a reaction mixture (40 µl) containing 15 µM ATP, 10 mM MgCl2, 10 mM MnCl2, and 3 µCi of [gamma -32P]ATP. The reaction was terminated by adding 8 µl of 6 × electrophoresis sample buffer and boiling for 5 min. c-Src activity was measured by autophosphorylation exactly as described previously (22). Samples were analyzed on 9% SDS-PAGE, followed by autoradiography. BMK1 and c-Src autophosphorylation were determined by densitometry of bands at the correct molecular weights in the linear range of film exposure using a scanner and NIH Image 1.54.

Cell Adhesion Asssay

The adhesion assay was performed as described previously (23). Briefly, cells were incubated at 37 °C in 2 mM EDTA in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3) for 5 min and detached from dishes by gentle pipetting. The cells were washed three times with RPMI 1640, collected by low speed centrifugation, and resuspended in RPMI 1640 with 0.1% bovine serum albumin. 1 × 106 cells were placed onto 60-mm bacteriologic plastic dishes coated with fibronectin and incubated at 37 °C. The bacteriological plastic dishes and plates were coated with human fibronectin (10 µg/ml) for 16 h at 4 °C, and nonspecific binding sites were blocked with 1% heat-denatured bovine serum albumin in PBS for 1 h at room temperature. Prior to use the dishes and plates were rinsed three times with PBS.

Materials

All materials were from Sigma except where indicated. H2O2 was from Fisher, and CP-118,556 was from Pfizer.

Statistical Analysis

Data are reported as mean ± S.D. Differences were analyzed with unpaired two-tailed Student's t test, or Welch's t test as appropriate.


RESULTS

BMK1 Kinase Phosphorylation Is Associated with a Mobility Shift

As reported previously (10), BMK1 resembles other members of the MAP kinase family in that it has a consensus TXY phosphorylation motif (specifically TEY) that upon dual phosphorylation is associated with stimulation of kinase activity. However, BMK1 differs from other MAP kinase family members by virture of its larger size as shown by Western blot analysis with BMK1 carboxyl-terminal antibody, which revealed a prominent 110-kDa protein band in cultured fibroblasts (Fig. 1). H2O2 caused a retardation in electrophoretic mobility of immunoreactive BMK1 that was readily detected on Western blot as two distinct bands of higher apparent molecular weight. We interpret these bands to represent phosphorylated BMK1, although the precise sites of phosphorylation are unknown. However, the highest molecular weight band has the same apparent molecular weight as the autophosphorylated protein band shown in subsequent figures, suggesting that these BMK1 proteins have undergone TEY phosphorylation. A similar band shift has been reported for the p42 and p44 MAP kinases when they undergo phosphorylation on T and Y (24).


Fig. 1. Analysis of BMK1 kinase phosphorylation by Western blot mobility shift and autophosphorylation. Growth-arrested mouse fibroblasts were stimulated for 20 min with 200 µM H2O2. Cell lysates were prepared and BMK1 immunoprecipitated. An immune complex protein kinase assay using [gamma -32P]ATP was performed, protein was separated on 8% SDS-PAGE, and then analyzed by Western blotting (A) and subsequent autoradiography for autophosphorylation (B). Hyperphosphorylated (pBMK1) and unphosphorylated (BMK1) forms of BMK1 are indicated. Note: to achieve adequate separation, the gel front was run for 4 h after the dye front had reached the bottom.
[View Larger Version of this Image (30K GIF file)]

H2O2 Stimulates BMK1 Kinase Activity

Stimulation of BMK1 kinase activity by H2O2 was measured by the change in electrophoretic mobility on Western blot (Fig. 2A), by autophosphorylation (Fig. 2B), and by myelin basic protein phosphorylation (not shown). In serum-deprived quiescent cells, BMK1 was almost exclusively in the unphosphorylated, lower molecular weight form (Fig. 2A). Stimulation with 200 µM H2O2 for 20-40 min markedly increased the higher molecular weight forms of BMK1.


Fig. 2. H2O2 activates BMK1: time course. Growth-arrested fibroblasts were treated with 200 µM H2O2 for the indicated times. BMK1 kinase activity was analyzed by mobility shift on Western blot (A) and by autophosphorylation (B) in an immune complex kinase assay using [gamma -32P]ATP as described in the legend to Fig. 1. The extent of autophosphorylation was quantified by densitometry of autoradiograms (C). Results from four experiments were normalized by arbitrarily setting the densitometry of control cells (time = 0) to 1.0 (± S.D.).
[View Larger Version of this Image (20K GIF file)]

Because it was difficult to quantitate BMK1 kinase activity by Western blot analysis, we performed an in vitro kinase assay based on BMK1 autophosphorylation activity. The time course for BMK1 autophosphorylation (Fig. 2, B and C) was similar to that observed for changes in electrophoretic mobility (Fig. 2A) with peak activation at 20 min. The H2O2-induced increase in BMK1 autophosphorylation was not due to changes in BMK1 protein expression. There was a good correlation between the magnitude and time course of BMK1 autophosphorylation and in vitro phosphorylation of myelin basic protein. Because the autophosphorylation assay was more reproducible and of greater magnitude it was chosen for subsequent experiments. The role of autophosphorylation of BMK1 in functional activation is unknown at this time.

H2O2 Activates c-Src in Fibroblasts

Previous investigators have suggested that c-Src may be an upstream mediator of redox-sensitive signal transduction (16). To explore the role of c-Src in H2O2-mediated signal transduction in fibroblasts, we measured c-Src kinase activity by an immune complex assay with c-Src autophosphorylation. c-Src activity increased within 2 min in response to 200 µM H2O2 (Fig. 3) with a maximum 3.1 ± 1.0-fold increase 5 min after H2O2 stimulation. No difference in c-Src protein expression was observed in lysates from control and H2O2-stimulated cells as determined by immunoprecipitation and Western blot analysis with anti-Src antibody.


Fig. 3. H2O2 activates c-Src: kinase activity measured by c-Src autophosphorylation. Growth-arrested fibroblasts were treated with 200 µM H2O2 for the indicated times, and cell lysates were prepared with RIPA buffer for the c-Src autophosphorylation assay. The kinase reaction was performed as described under "Experimental Procedures." After SDS-PAGE, autophosphorylation was measured by densitometry in the linear range of film development. To verify equal loading, c-Src immunoprecipitates were analyzed by immunoblotting with c-Src antibody. A, representative autoradiogram (top) and Western blot analysis (bottom). B, densitometric analysis of c-Src autophosphorylation. Results were normalized to control (time = 0), which was arbitrarily set to 1.0. Results are mean ± S.D. (n = 3).
[View Larger Version of this Image (30K GIF file)]

Both Herbimycin A and CP-118,556 Inhibit BMK1 Activation by H2O2

To determine whether c-Src is an upstream signaling mediator of BMK1, we studied the effect of two different inhibitors, herbimycin A and CP-118,556, on H2O2-mediated BMK1 activity (Fig. 4). These two reagents have been shown to exhibit specificity for inhibition of c-Src (25, 26). Herbimycin A, a benzoquinone ansamycin antibiotic, inhibits Src family kinases by covalent interactions with sulfhydryl groups (25) and by disrupting Src interactions with heat shock proteins (especially HSP90) (27). CP-118,556, a pyrazolopyrimidine, interacts specifically with Src family kinases and is a competitive inhibitor of ATP (25). CP-118,556 inhibits Src family kinases preferentially compared with ZAP-70, JAK2, and the epidermal growth factor receptor (25), although the relative specificity for inhibition of individual Src family kinases is not established. Herbimycin A and CP-118,556 caused a concentration-dependent inhibition of H2O2-mediated BMK1 activation with approximate IC50 values of 0.3 and 1 µM, respectively.


Fig. 4. Herbimycin A and CP-118,556 inhibit BMK1 activation by H2O2. Growth-arrested fibroblasts were pretreated with 0.1% Me2SO for 16 h (Control) and the indicated concentrations of herbimycin A for 16 h (A) or CP-118,556 for 15 min (B). BMK1 kinase activity was determined by immune complex kinase assay using [gamma -32P]ATP and measured after SDS-PAGE by autoradiography. No difference in the amount of BMK1 was observed in lysates from control and treated cells by Western blot analysis with BMK1 antibody (data not shown).
[View Larger Version of this Image (28K GIF file)]

Activation of BMK1 in Response to H2O2 Is Dependent on c-Src, but Not Fyn

The ability of herbimycin A and CP-118,556 to inhibit BMK1 activation by H2O2 suggested an important role for c-Src. To verify that activation of BMK1 occurred by a c-Src-dependent mechanism, we utilized cells derived from mice deficient in c-Src kinase family members (19). There was no immunoreactive c-Src in Src-/- cells, while immunoreactive Fyn was expressed equally (or to a greater extent) than in wild type cells (Fig. 5, top). Likewise, there was no immunoreactive Fyn in (Fyn-/-) cells, while there was no change in expression of c-Src in Fyn-/- cells compared with the wild type cells (Fig. 5, top). H2O2 stimulated BMK1 activity in wild type fibroblasts that was maximal at 20 min (Fig. 6, right). In contrast, in Src-/- fibroblasts, H2O2 failed to stimulate BMK1 activity at any time (Fig. 6, left). Interestingly, in Fyn-/- fibroblasts, H2O2 enhanced BMK1 activity by 69 ± 19% compared with the wild type cells (Fig. 7). These results indicate that H2O2 activation of BMK1 is dependent on c-Src, but not Fyn. To confirm that Src-/- cells are sufficiently healthy to mediate a Src-independent responses, we investigated protein tyrosine phosphorylation stimulated by adhesion in Src-/- and wild type fibroblasts. Anti-phosphotyrosine Western blot analysis of total cell lysates showed that adhesion to fibronectin (a ligand for alpha 3,4,5,vbeta 1, alpha vbeta 3, alpha vbeta 5, and alpha vbeta 6 integrins) stimulated tyrosine phosphorylation of 72-75-, and 110-kDa proteins, and there was no significant difference in the tyrosine phosphorylation of these proteins in Src-/- cells compared with the wild type cells (Fig. 8). To investigate the role of Src further we studied NIH-3T3 wild type (WT-3T3) and v-Src-transformed (v-Src-3T3) cells. There was significantly more immunoreactive Src in the v-Src cells (Fig. 5, bottom). In addition, there was significantly greater BMK1 activation (7.1 ± 1.4-fold increase) in the v-Src cells under basal conditions than in wild type-3T3 cells (Fig. 9).


Fig. 5. Western blot analysis of c-Src and Fyn expression in Src- and Fyn-deficient fibroblasts and v-Src overexpressing 3T3 cells. Wild type mouse fibroblast (WT), Src knockout (Src-/-), and Fyn knockout (Fyn-/-) cells were harvested and Western blot analysis was performed on whole cell lysates using anti-Src antibody (top: left panel) and anti-Fyn antibody (top: right panel). Total cell lysates from nontransformed NIH-3T3 (WT) and v-Src-transformed NIH-3T3 (v-Src) cells were immunoprecipitated with anti-Src antibody. Protein precipitates were analyzed by immunoblotting with anti-Src antibody (bottom panel).
[View Larger Version of this Image (31K GIF file)]


Fig. 6. H2O2 activation of BMK1 is inhibited in Src-deficient cells. Mouse fibroblasts were prepared from two different transgenic cell lines: wild type (WT) and c-Src-deficient cells (Src-/-). Cells were stimulated for the indicated times with 200 µM H2O2 and BMK1 kinase activity measured by autophosphorylation. No difference in the amount of BMK1 was observed in lysates from any of the cell lines by Western blot analysis with BMK1 antibody (data not shown). Densitometric analysis of BMK1 activation is shown at the bottom. Results were normalized by arbitrarily setting the densitometry of control cells (time = 0) to 1.0 (shown is mean ± S.D., n = 3).
[View Larger Version of this Image (25K GIF file)]


Fig. 7. H2O2 activation of BMK1 is not inhibited in Fyn-deficient cells. Fyn knockout cells (Fyn-/-) and wild type (WT) cells were treated with 200 µM H2O2 and BMK1 kinase activity measured by autophosphorylation. Densitometric analysis of BMK1 activation is shown at the bottom. Results were normalized by arbitrarily setting the densitometry of control cells (time = 0) to 1.0 (shown is mean ± S.D., n = 3).
[View Larger Version of this Image (28K GIF file)]


Fig. 8. Protein tyrosine phosphorylation stimulated by adhesion is similar in wild type (WT) and Src knockout cells (Src-/-). Cells were detached and placed onto plastic dishes coated with fibronectin (FN, 10 mg/ml). Cell lysates were prepared and Western blot analysis performed with anti-phosphotyrosine monoclonal antibody (4G10). Arrows indicate adhesion-regulated phosphorylated proteins.
[View Larger Version of this Image (68K GIF file)]


Fig. 9. BMK1 activation is increased in v-Src-transformed NIH-3T3 cells. Cell lysates of growth arrested nontransformed NIH-3T3 cells (WT) and v-Src-transformed NIH-3T3 (v-Src) were immunoprecipitated with anti-BMK1 antibody and BMK1 kinase activity measured by autophosphorylation. Shown are samples from two different cell preparations. Densitometric analysis of BMK1 activation is shown at the bottom. Results were normalized by arbitrarily setting the densitometry of nontransformed NIH-3T3 cells (time = 0) to 1.0 (shown is mean ± S.D., n = 5).
[View Larger Version of this Image (21K GIF file)]


DISCUSSION

The major finding of this paper is that H2O2-mediated BMK1 activation requires c-Src. Redox-sensitive regulation of BMK1 is thus a new function for c-Src. Data that support an essential role for c-Src in H2O2-mediated BMK1 activation include the following. 1) The time course for c-Src activation was rapid (peak at 5 min) and preceded BMK1 activation (peak at 20 min). 2) c-Src inhibitors, herbimycin A and CP-118,556, blocked BMK1 activation by H2O2 at concentrations consistent with a specific effect on c-Src. 3) In Src-/- fibroblasts, there was no BMK1 activation in response to H2O2. In contrast, in Fyn-/- fibroblasts, H2O2 stimulated BMK1 activation significantly. 4) In v-Src-transformed NIH-3T3 cells BMK1 activation was increased relatively to wild type fibroblasts. Our results are the first to show that c-Src, but not Fyn, is involved specifically in oxidative stress-mediated BMK1 activation.

Previous investigators have suggested that c-Src may be an upstream mediator of redox-sensitive signal transduction based on findings with UV irradiation (16). There are at least nine members of the Src family of cytoplasmic protein kinases. Three family members (c-Src, Fyn, and Yes) are expressed ubiquitously and studies suggest that their functions may be at least partially overlapping (28). In the present study we observed that c-Src, but not Fyn, was required for H2O2-mediated BMK1 activation. This result suggests that unique activators of c-Src, but not Fyn, are generated by H2O2 in fibroblasts. Future studies will be required to define the precise nature of these activators.

Several investigators (29-32), including our group (17, 33), have suggested that reactive oxygen species regulate cell function by stimulating many of the same signal transduction pathways utilized by growth factors. For example, both platelet-derived growth factor and superoxide activate ERK1/2 in vascular smooth muscle cells, stimulate c-fos and c-myc expression, and increase DNA synthesis (17, 33). Other investigators have shown that reactive oxygen species stimulate increases in intracellular calcium and raise intracellular pH (31). However, several results suggest that activation of BMK1 by reactive oxygen species does not occur via a pathway shared by growth factors. First, we showed previously that activation of BMK1 occurred in response to H2O2 and sorbitol but not to growth factors such as platelet-derived growth factor and phorbol esters (12). Second, growth factors stimulate ERK1/2 in rat aortic smooth muscle cells, while H2O2 does not (17). Finally, growth factors such as angiotensin II and platelet-derived growth factor stimulate paxillin phosphorylation in smooth muscle cells and fibroblasts (34), but H2O2 does not (data not shown). These findings suggest that H2O2 uses a unique signal pathway to activate BMK1 which is different from growth factors.

Activation of BMK1 by H2O2 likely reflects a balance between positive and negative regulators as shown for other members of the MAP kinase family. For example, ERK1/2 is positively regulated by MAP kinase/ERK kinase and negatively regulated by the MAP kinase phosphatase-1. To date the phosphatase responsible for inactivating BMK1 has not been identified. c-Src itself is positively and negatively regulated by dephosphorylation and phosphorylation. One of the residues that appears to be critical for regulation of c-Src is Tyr530, which is not present in v-Src. Phosphorylation of Tyr530 by Csk (C Src kinase) family members inhibits c-Src activity (35), whereas dephosphorylation of this residue appears to be an activating mechanism. Phosphorylation of Tyr419 in the catalytic domain may be an activating signal, although the kinase(s) responsible have not been identified. Future work, including analysis of Csk function and phosphorylation of specific c-Src residues, will be necessary to identify the mechanisms for c-Src activation in response to H2O2.

In summary, we have shown that c-Src and BMK1 are activated by oxidative stress in fibroblasts. The fact that BMK1 is not activated by growth factors indicates that c-Src-mediated activation of BMK1 represents a growth-independent function of c-Src. Furthermore, the demonstration that H2O2-mediated activation of BMK1 required Src, but not Fyn, suggests that these two Src family kinases serve different intracellular functions with respect to oxidative stress and that the c-Src-BMK1 signaling pathway may involve novel intracellular mediators.


FOOTNOTES

*   This work was supported by a grant from the Japanese Heart Foundation and Bayer Yakuhin Research Grant Abroad to J. Abe and by National Institutes of Health Grants HL44721 and HL49192 (to B. C. B.) and GM53214 (to J. D. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Established Investigator of the American Heart Association. To whom correspondence should be addressed: Cardiology Division, Box 357710, University of Washington, Seattle, WA 98195. Tel.: 206-685-6960; Fax: 206-616-1580; E-mail: bcberk{at}u.washington.edu.
1   The abbreviations used are: MAP kinase, mitogen-activated protein kinase; BMK1, big mitogen-activated protein kinase 1; DTT, dithiothreitol; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal protein kinase; PAGE, polyacrylamide gel electrophoresis; SAPK, stress-activated protein kinase; PBS, phosphate-buffered saline.

ACKNOWLEDGEMENT

We thank U. Schmitz from the Berk laboratory for critical reading of this manuscript.


REFERENCES

  1. Blenis, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5889-5892 [Abstract]
  2. Davis, R. J. (1993) J. Biol. Chem. 268, 14553-14556 [Free Full Text]
  3. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994) Nature 369, 156-160 [CrossRef][Medline] [Order article via Infotrieve]
  4. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037 [Medline] [Order article via Infotrieve]
  5. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) Science 265, 808-811 [Medline] [Order article via Infotrieve]
  6. Marais, R., Wynne, J., and Treisman, R. (1993) Cell 73, 381-393 [Medline] [Order article via Infotrieve]
  7. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Science 270, 1326-1331 [Abstract]
  8. Gupta, S., Campbell, D., D'Erijard, B., and Davis, R. J. (1995) Science 267, 389-393 [Medline] [Order article via Infotrieve]
  9. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) J. Biol. Chem. 270, 7420-7426 [Abstract/Free Full Text]
  10. Lee, J. D., Ulevitch, R. J., and Han, J. (1995) Biochem. Biophys. Res. Commun. 213, 715-724 [CrossRef][Medline] [Order article via Infotrieve]
  11. Zhou, G., Bao, Z. Q., and Dixon, J. E. (1995) J. Biol. Chem. 270, 12665-12669 [Abstract/Free Full Text]
  12. Abe, J., Kusuhara, M., Ulevitch, R. J., Berk, B. C., and Lee, J.-D. (1996) J. Biol. Chem. 271, 16586-16590 [Abstract/Free Full Text]
  13. Auch-Schwelk, W., Bossaller, C., Claus, M., Graf, K., Grafe, M., and Fleck, E. (1992) J. Cardiovasc. Pharmacol. 9, S62-S67
  14. Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., and Willett, W. C. (1993) N. Engl. J. Med. 328, 1444-1449 [Abstract/Free Full Text]
  15. Halliwell, B. (1989) Br. J. Exp. Pathol. 70, 737-757 [Medline] [Order article via Infotrieve]
  16. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992) Cell 71, 1081-1091 [Medline] [Order article via Infotrieve]
  17. Baas, A. S., and Berk, B. C. (1995) Circ. Res. 77, 29-36 [Abstract/Free Full Text]
  18. Bolen, J. B., Rowley, R. B., Spana, C., and Tsygankov, A. Y. (1992) FASEB J. 6, 3403-3409 [Abstract/Free Full Text]
  19. Thomas, S. M., Soriano, P., and Imamoto, A. (1995) Nature 376, 267-271 [CrossRef][Medline] [Order article via Infotrieve]
  20. Imamoto, A., and Soriano, P. (1993) Cell 73, 1117-1124 [Medline] [Order article via Infotrieve]
  21. Johnson, P. J., Coussens, P. M., Danko, A. V., and Shalloway, D. (1985) Mol. Cell. Biol. 5, 1073-1083 [Medline] [Order article via Infotrieve]
  22. Ishida, M., Marrero, M. B., Schieffer, B., Ishida, T., Bernstein, K. E., and Berk, B. C. (1995) Circ. Res. 77, 1053-1059 [Abstract/Free Full Text]
  23. Takahashi, M., and Berk, B. C. (1996) J. Clin. Invest. 98, 2623-2631 [Abstract/Free Full Text]
  24. Posada, J., and Cooper, J. A. (1992) Science 255, 212-215 [Medline] [Order article via Infotrieve]
  25. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., and Connelly, P. A. (1996) J. Biol. Chem. 271, 695-701 [Abstract/Free Full Text]
  26. Levitzki, A., and Gazit, A. (1995) Science 267, 1782-1788 [Medline] [Order article via Infotrieve]
  27. Whitesell, L., Mimnaugh, E. G., De, C.-B., Myers, C. E., and Neckers, L. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8324-8328 [Abstract]
  28. Lowell, C. A., Soriano, P., and Varmus, H. E. (1994) Genes Dev. 8, 387-398 [Abstract]
  29. Bauskin, A. R., Alkalay, I., and Ben-Neriah, Y. (1991) Cell 66, 685-696 [Medline] [Order article via Infotrieve]
  30. Abate, C., Patel, L., Raushcer, F. J., III, and Curran, T. (1990) Science 249, 1157-1161 [Medline] [Order article via Infotrieve]
  31. Shibanuma, M., Kuroki, T., and Nose, K. (1988) J. Cell. Physiol. 136, 379-383 [Medline] [Order article via Infotrieve]
  32. Shibanuma, M., Kuroki, T., and Nose, K. (1990) Oncogene 5, 1025-1032 [Medline] [Order article via Infotrieve]
  33. Rao, G. N., and Berk, B. C. (1992) Circ. Res. 70, 593-599 [Abstract]
  34. Polte, T. R., Naftilan, A. J., and Hanks, S. K. (1994) J. Cell. Biochem. 55, 106-119 [Medline] [Order article via Infotrieve]
  35. Klages, S., Adam, D., Class, K., Fargnoli, J., Bolen, J. B., and Penhallow, R. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2597-601 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.